Search

everythinglearnresearchcommunity

for

Search:↓

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

ESR2 gene variations may be linked to female pattern hair loss.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Truncated hHb1 keratin may play a role in breast cancer cell transformation.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Mutations in the RBPJ gene cause Adams-Oliver Syndrome.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Localized breast cancer can affect skin and hair.

Complex basal cell carcinomas need personalized treatment due to unique genetic mutations.

A mutation in the EDNRA gene causes Oro-Oto-Cardiac syndrome, affecting face and heart development.

Seven new genetic risk areas for prostate cancer were found.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

PRDX5 enzyme may contribute to alopecia areata by affecting oxidative stress and autoimmunity.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.